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stroke risk compared with controlled hypertension, whereas evening hypertension was not. Conversely, the Finn-Home Study, a prospective white population-based cohort study, found that morning and evening BP had equal predictive value for CVD events. 15 This discrepancy may be attributable to an international variation in the burden of 2 representative CVD events: coronary artery disease (CAD) and stroke. 16 That is, the incidence of stroke is more common than that of CAD in Asian countries, but CAD outweighs stroke in Western countries. 17 Stroke is more sensitive than the risk of CAD to high BP. 18 Therefore, we hypothesized that, in Asian populations, the simultaneous assessment of morning and evening BP instead of morning BP alone may underestimate CVD, particularly stroke risks.
Using a nationwide Japanese database of patients with a history of or risk factors for CVD, or both, we sought to compare the predictive ability between morning and evening home BP and between morning and combined morning and evening home BP for distinct cardiovascular outcomes (ie, stroke and CAD).
Methods

Study Design
The Japan Morning Surge-Home Blood Pressure (J-HOP) study 19 is a prospective observational study (University Hospital Medical Information Network Clinical Trials Registry, UMIN000000894) of 4310 patients with a history of or risk factors for CVD, or both, who were recruited between 2005 and 2012 and followed up through March 2015 by 75 doctors at 71 institutions (45 primary practices, 22 hospital-based outpatient clinics, and 4 specialized university hospitals; see online-only Data Supplement). Details of the study design and methods are described in the online-only Data Supplement. All participants provided written informed consent, and the Institutional Review Board of Jichi Medical School approved the study.
BP and Other Measurements
Details of the Methods have been described in the online-only Data Supplement. Three office BP readings were taken at 15-second intervals on 2 different occasions, and their mean (6 readings) was defined as the office BP. Self-measured home BP values were obtained according to the current guideline. 3 Three home BP readings were taken at 15-second intervals with subjects in a seated position in both the morning (within 1 hour of waking and before taking antihypertensive medication) and evening (before going to bed) for 14 days. The first day home BP measures were excluded, 20 and the averages of the remaining morning (37.6±7.9 readings) and evening BP (37.0±8.0 readings) measures were calculated separately. This protocol provided several advantages over the prior home BP studies (Table S1 in the online-only Data Supplement). [4] [5] [6] [7] [8] [9] [10] First, the office and home BP were measured using the same validated, automatic, and oscillometric device (HEM-5001; Omron Healthcare Co., Ltd.) 19 In addition, to avoid reporting bias, BP data were automatically stored in the memory of the BP device and were downloaded to a computer by a physician or nurse during clinic visits. And finally, the present study had more BP readings than the previous home BP studies. [4] [5] [6] [7] [8] [9] [10] Laboratory methods are presented in the online-only Data Supplement. In 4264 of the total 4310 subjects, the spot urine albumin:creatinine ratio and plasma brain natriuretic peptide levels were also assessed at baseline.
Outcomes Ascertainment
Vital status was ascertained through March 2015, with an average follow-up period of 4.0±2.1 years (16 929 person-years). The outcomes were categorized as follows: (1) fatal and nonfatal stroke, defined as sudden onset of a neurological deficit persisting for ≥24 hours in the absence of any other disease that could account for the symptoms, with the findings of brain computed tomography or magnetic resonance imaging. Transient ischemic attack was not included. (2) Fatal and nonfatal CAD, defined as acute myocardial infarction, angina pectoris requiring percutaneous coronary intervention, and sudden death within 24 hours of the abrupt onset of symptoms. If events occurred on ≥2 occasions, the first occurrence was included in the analysis. Evidence on the above CVD outcomes was ascertained by ongoing reports from a general physician at each institute. The incident stroke and CAD were also ascertained by means of annual or more frequent reviews of patients' medical records. When patients failed to come to the hospital, we interviewed them or their families by telephone, or both. The end point committee adjudicate all events by reviewing the patients' files and source documents or by requesting more detailed written information from investigators. The committee was blinded to individual clinical characteristics including home BP data. A final follow-up survey to reconfirm the clinical outcomes was performed from September 2014 to March 2015. Additional details are given in the online-only Data Supplement.
Statistical Analyses
All statistical analyses were performed with SPSS version 18.0J software (SPSS, Chicago, IL) and STATA version 12.1 (STATACorp, College Station, TX). The associations between home BP and demographic and clinical characteristics of the patients were calculated by Pearson correlation method or unpaired Student t test.
We used Cox proportional hazards models to examine the associations between home BP measures and risks for incident stroke and CAD. Covariates included traditional risk factors (age, sex, current smoking, a history of diabetes mellitus, total cholesterol, high-density lipoprotein cholesterol, and office systolic BP [SBP] or diastolic BP [DBP]), 21 body mass index, statin use, antihypertensive medication use, and pre-existing CVD (ie, angina pectoris, acute myocardial infarction, and stroke). The model including these covariates was defined as the base model. In separate analyses, we included urine albumin:creatinine ratio and brain natriuretic peptide as adjusted factors; the sample size was reduced (n=4264) because of missing data on covariates.
We calculated the hazard ratios (HRs) and 95% confidence intervals (CIs) for stroke and CAD events associated with higher morning, evening, and combined morning and evening BP. The likelihood ratio values were used to evaluate the goodness-of-fit of predictive models. Comparison of the discriminative ability of each model was conducted by Harrell C statistics (with 95% CIs, calculated by bootstrapping) as described by Newson. 22 We evaluated category-based/categoryfree net reclassification improvement. 23 Because no established categories exist that guide clinical decisions for CVD risk in Asians with cardiovascular risk factors, we used the standard cutoff values for 10-year CVD risk (<10%, 10% to <20%, and ≥20%; roughly equivalent to <5%, 5%-9%, and ≥10% in 4-5 years). 24 We then calculated the proportion of participants who were reclassified by the comparison model compared with the base model. We also computed the integrated discrimination improvement, which compares the integrals of sensitivity and specificity under 2 models. A 2-sided P<0.05 was defined as statistically significant.
Results
Of the 4310 participants obtained entry data, 32 participants were lost to follow-up. The included participants (n=4278) had a lower percentage of men (46.9% versus 65.6%) and lower evening DBP (72.6 versus 77.6 mm Hg; both P<0.05) than those lost to follow-up (n=32 ; Table S2 ). Age; the proportion of antihypertensive medication use; and pre-existing CVD at baseline, office SBP, and DBP, and morning SBP and DBP were similar between them. Table 1 provides the demographic variables and clinical characteristics of the included  patients. Tables S3 and S4 show the associations of morning and evening BP with clinical characteristics. Higher age, higher body mass index, and fasting glucose were associated with higher morning and evening SBP and DBP (correlation coefficient=0.09-0.22; all P<0.001). Morning SBP was higher, whereas evening SBP was lower in men than in women. Daily drinking was associated with lower evening but not with morning SBP. Those with pre-existing CVD at baseline showed slightly higher morning SBP than those without it. Figure S1 show the HRs and 95% CIs for incident stroke and CAD according to morning and evening BP categories, with adjustment for covariates. Using a reference of SBP<135 mm Hg and DBP<85 mm Hg, which is the targeted threshold recommended in several guidelines, 1-3 stroke risks associated with higher BP were steeper when morning SBP instead of evening SBP was used, whereas neither morning nor evening SBP was associated with CAD risks (Figure) .
With adjustment for covariates, the results from Cox proportional hazards models suggested that a 10-mm Hg increase in morning and evening SBP was associated with a higher risk for stroke (Table 2 ). When morning and evening SBP were entered into the same model, only morning SBP was associated with stroke risk (HR, 1.35; 95% CI, 1.13-1.62). The model fit assessed by −2 log-likelihood ratio changes was more improved when we added morning SBP instead of evening or combined morning and evening SBP into the base models. Further adjustments for drinking status, all classes of antihypertensive medication (eg, angiotensin receptor blockers and calcium-channel blockers), and evening dosing of antihypertensive medications did not change the results (data not shown). Adjustments for urine albumin:creatinine ratio and brain natriuretic peptide attenuated the associations, but higher morning SBP remained significantly associated with stroke risk (HR, 1.33-1.34 by 10-mm Hg increase). Neither morning nor evening SBP and DBP were associated with CAD risks, whereas diabetes mellitus (HR, 1.95-2.04), total cholesterol (HR, 1.01 by 1 mg/dL increase), and high-density lipoprotein cholesterol (HR, 0.97-0.98 by 1-mg/dL increase; all P<0.05) were all significantly associated with CAD risk. Table 3 shows analyses of calibration and discrimination of predictive models. Morning DBP and evening SBP/DBP were not evaluated because they showed no associations with outcomes in Cox analyses (Table 2 ). For stroke, the C statistic for the base model was 0.756 (95% CI, 0.646-0.866), which increased to 0.802 (95% CI, 0.692-0.911; P = 0.077) by adding morning SBP, but only changed slightly with the addition of evening SBP or combined morning and evening SBP (both P=NS; Table 3 , model 1). The C statistics differed significantly between the models including morning versus evening SBP (C statistics difference, 0.038; 95% CI, 0.012-0.064) and between the model including morning versus combined morning and evening SBP (C statistics differences, 0.017; 95% CI, 0.004-0.030; both P<0.05). Morning SBP provided greater category-free net reclassification improvement, absolute/ relative integrated discrimination improvement (Table 3) , and total number of correctly reclassified participants for stroke events than evening SBP and mean morning and evening SBP (Table 4; Tables S6 and S7) .
Overall patterns in the associations of stroke risk with morning SBP, evening SBP, and mean morning and evening BP were similar in sensitivity analyses by sex, obesity, preexisting CVD, diabetes mellitus, drinking status, and antihypertensive medication use ( Figure S2 ). There were no 
Discussion
Results from this nationwide study of 4278 Japanese with a history of or risk factors for CVD, or both, demonstrated that morning home SBP provided superior discrimination and risk reclassification for incident stroke compared with evening SBP. The predictive ability of morning SBP was attenuated by the simultaneous assessments of morning and evening SBP. Neither morning nor evening SBP was associated with incident CAD risk. To ensure best stroke prediction in clinical practice, morning home SBP itself should be evaluated. At least 7 cohorts (5 general populations and 2 general practice populations) [4] [5] [6] [7] [8] [9] [10] have assessed longitudinal associations between home BP measures and incident CVD events (Table S1 ). They found that combined morning and evening SBP is associated with CVD events, independently of office SBP. [4] [5] [6] [7] [8] Only COX analyses were conducted in these studies, [4] [5] [6] [7] [8] [9] [10] and thus the clinical utility of home BP measurement has remained uncertain. 23 This limitation was resolved in the present study, which evaluated the discrimination and recalibration of risk prediction models. The C statistics change when morning home SBP was added to the model (including traditional factors, body mass index, statin use, antihypertensive medication use, and pre-existing CVD) was substantial (+0.05), resulting in a C statistics value >0.80. Net reclassification improvement and integrated discrimination improvement were also calculated, and the greatest achievement was observed by morning SBP, ie, morning SBP values best reclassified individuals with stroke events to higher predicted-risk strata and those without stroke events to lower predicted-risk strata (Table 4) .
Several mechanisms are suggested to potentially underlie the associations between morning SBP (but not evening SBP) and stroke risk. First, in our study, 80% of subjects were on antihypertensive medication, so the higher morning SBP than the evening SBP may have been because of an inconsistent BP-lowering effect of antihypertensive drugs over the course of 24 hours. 2, 12, 13 Second, morning BP is more reflective of certain pathophysiological conditions compared with evening BP, such as obesity, sleep apnea, and various target-organ damages (eg, left ventricular hypertrophy, albuminuria, and vascular dysfunction). 19, 25, 26 However, in our study, the association of morning SBP with stroke risk was independent of organ damage markers (ie, microalbuminuria and brain natriuretic peptide values). This suggests that higher morning SBP may not be merely an epiphenomenon of comorbidities, but causally related to stroke occurrence. Third, increased hemodynamic stress with excess BP variability after waking, alone or in combination with other physiological changes in the morning (eg, impaired hemostasis and neuroendocrine imbalance), may trigger stroke events. 26, 27 Evening home SBP has been shown to be lower than morning home SBP in Asians (−3 to −2 mm Hg), whereas the opposite is true in Europeans (+1 to +4 mm Hg). 10, 14, 15 An ambulatory BP monitoring study has also suggested a similar pattern. 27 Alcohol use lowers evening BP in Asians but has a less pronounced effect in whites, 28, 29 which might account for the racial disparity in the morning−evening BP difference. However, the morning−evening SBP difference remained unchanged even when daily drinkers were excluded (Table S4) . Cultural diversity (eg, evening activities, bathing frequency, time and content of dinners, and time of evening BP measures) is another potential contributor to the racial difference. 13 Although patients were instructed to avoid smoking, alcohol use, eating, exercise, and bathing before home BP measurements, whether patients followed up these instructions is unknown. Ultimately, evening home BP in Asians may be confounded by certain cultural patterns, and therefore may not be comparable with home morning BP in predicting cardiovascular outcomes. Further investigations will be needed to discern whether the clinical implications of evening home BP differ by race.
In the present study, home SBP/DBP values were not associated with incident CAD risks, whereas diabetes mellitus, higher total cholesterol, and lower high-density lipoprotein cholesterol were associated with such risks. The prior home BP studies did not evaluate risk associations by distinct cardiovascular outcomes (ie, CAD and stroke, separately). [4] [5] [6] [7] [8] [9] [10] Conversely, the International Database on Base models include age, sex, body mass index, current smoking, a history of diabetes mellitus, statin use, antihypertensive medication use, pre-existing cardiovascular disease, total cholesterol, high-density lipoprotein, and office SBP (or office DBP when home DBP was analyzed). Δ indicates change of degree in −2 log-likelihood ratio test from the base model to the new model including morning or evening home BP home. Morning and evening mean BP is defined as (morning BP+evening BP)/2. BP indicates blood pressure; CAD, coronary artery disease; CI, confidence interval; DBP, diastolic blood pressure; HR, hazard ratio; and SBP, systolic blood pressure.
Statistical significance was defined as P<0.05. *P<0.001, and †P<0.01. HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO), 30 which combined the aforementioned study data sets, 6, 8, 10 assessed the associations of home BP (combined morning and evening BP) with distinct CVDs. The results were consistent with our findings; home SBP was associated with increased risk for incident stroke but not for CAD in patients on antihypertensive medication. 30 By contrast, home SBP was associated with CAD risk among untreated individuals. 30 Because of the limited number of untreated individuals, we were not enable to discern whether antihypertensive medication use confounds the association between home BP and CAD risk.
The major strengths of this study were its nationwide scope, its application of standardized office and home BP measurements (eg, automatic monitors equipped with a memory, equivalent numbers of measurements, and equivalent intervals between readings), and its excellent follow-up rate. However, there were limitations. First, we were unable to assess the impact of BP changes and the use of antihypertensive medication during follow-up. Our study was conducted in a medical practice setting, and hypertension treatment based on not only office BP but also home BP measurements is recommended for all Japanese physicians. 31 In aggregate, these factors would tend to underestimate the true associations of home BP with CVD risks. Second, our findings cannot be generalized to general populations and other race/ethnic groups, particularly those with culturally defined differences in evening activities (eg, alcohol use or the taking of hot baths). Third, we did not have sufficient power to conduct sensitivity analyses using C statistics and net reclassification improvement/integrated discrimination improvement. In addition, the small number of stroke events prevented subgroup analyses by stroke subtype or fatal and nonfatal events although the majority of stroke events were ischemic (81%) and the BP-related risks for ischemic and hemorrhagic stroke are generally similar. 32 Fourth, the covariate set used in the present study was limited, and residual confounders (eg, socioeconomic status and psychological factors) may exist. 33, 34 Finally, the clinical utility of home BP measures in terms of the cost-effectiveness and availability, as well as the potential risks associated with the test (eg, anxiety, self-modification of treatment), remains uncertain.
Perspectives
In this Japanese nationwide survey of general practice data >4 years of follow-up, morning home SBP improved the prediction of stroke risk and was superior to simultaneous assessment of morning and evening SBP. Our results emphasize the importance of focusing on not only home BP values but also their time of measurement to identify those who may be at risk for developing stroke. Morning home SBP itself may be an important therapeutic target for stroke prevention in clinical prevention practice, and this possibility should be tested in clinical trials. What Is New?
Sources of Funding
• We directly compared the discrimination and risk reclassification for the incident stroke and coronary artery disease between morning and evening home blood pressure in an Asian population.
What Is Relevant?
• Although several guidelines recommend that home blood pressure should be measured in both the morning and evening, there may be a noteworthy difference in prognostic relevance between morning and evening home blood pressure readings.
Summary
The present data demonstrated that morning home blood pressure readings provided superior discrimination and risk reclassification for incident stroke beyond traditional risk factors including office blood pressure, and the improved discrimination was attenuated by the simultaneous assessments of morning and evening blood pressure. Neither morning nor evening systolic blood pressure was associated with incident coronary artery disease.
Methods
J-HOP study
The hospital-based outpatient clinics, and 4 specialized university hospitals) agreed with the aims of this study and collected prospective data from individuals who agreed to participate in this project.
BP measurements
Office BP was measured by physicians or nurses using an upper arm cuff oscillometric BP device (HEM-5001; Omron Healthcare Co., Ltd). The Omron HEM-5001 home BP device uses the same BP measurement algorithm as used in the HEM-737 home BP device, which was validated in a previous study. 3 Three office BP readings were taken at 15-second intervals 4 in a sitting position. The analyses were performed using the mean values of 6 readings obtained during 2 clinic visits (before and after the home BP measurements). We advised the patients to take their morning medication as usual on the days when they were visiting the clinic.
Self-measured home BP values were obtained using the same device (HEM-5001). The patients were instructed to place a cuff of appropriate size on the same arm throughout the measurements and to measure their BP in a sitting position after ≥2 minutes of rest according to the Japanese Society of Hypertension 2004 guidelines. 5 Three home BP readings were taken at 15-second intervals in a sitting position in both the morning and evening for 14 days. Morning BP was measured within 1 hour of waking, after urination, before breakfast, and before taking antihypertensive medication. Evening BP was measured before going to bed, and the patients were instructed to avoid measuring their BP just after taking a bath, drinking alcohol, or smoking. The morning and evening BP data were automatically stored in the memory of the BP device and were downloaded to a computer by a physician or nurse during clinic visits. The data were then sent to the study control center (Jichi Medical University, Tochigi, Japan). After exclusion of the data from the first day, the averages of all home BP measures taken 3 times in the morning (morning home BP) and 3 times in the evening (evening home BP) for 13 days (78 readings in total) were separately calculated by the study coordinator, who was blinded to the clinical characteristics of the study participants.
Laboratory and other examinations
Blood and spot urine samples were collected in the morning in a fasting state at study enrollment. The blood samples were centrifuged at 3000 ×g for 15 minutes at room temperature.
Plasma/serum samples after separation and urine samples were stored at 4°C in refrigerated containers and sent to a commercial laboratory (SRL Inc., Tokyo) within 24 hours. Serum samples after separation were also stored at −80°C in a refrigerator. All assays were performed within 24 hours of sample collection at a single laboratory center (SRL Inc., Tokyo). Total cholesterol values were measured using the cholesterol dehydrogenase-UV method. Serum high-density-lipoprotein cholesterol was determined by the direct method using cholesterol oxidase. The urine albumin-to-creatinine ratio (n=4264) was measured using an immunoturbidity kit (AutoWako Microalbumin; Wako Pure Chemical Industries, Osaka, Japan).
The plasma level of BNP (MI02 Shionogi BNP; Shionogi, Osaka, Japan) was measured by using a chemiluminescent enzyme. Questionnaires were used to collect information on demographics, smoking and drinking status, medical history, and medication use. 
Outcomes ascertainment
